WallStSmart

Welltower Inc (WELL)vsChiron Real Estate Inc. (XRN)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 8223% more annual revenue ($12.76B vs $153.35M). XRN leads profitability with a 37.8% profit margin vs 12.1%. WELL appears more attractively valued with a PEG of 3.62. XRN earns a higher WallStSmart Score of 58/100 (C).

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20

XRN

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 5.7Quality: 6.0
Piotroski: 4/9Altman Z: -0.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

WELLSignificantly Overvalued (-74.6%)

Margin of Safety

-74.6%

Fair Value

$126.64

Current Price

$225.47

$98.83 premium

UndervaluedFair: $126.64Overvalued

Intrinsic value data unavailable for XRN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$162.69B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

XRN4 strengths · Avg: 9.5/10
P/E RatioValuation
9.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Profit MarginProfitability
37.8%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
23.2%8/10

Strong operational efficiency at 23.2%

Areas to Watch

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
101.3x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

XRN4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.8%4/10

4.8% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$503.33M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 37.8% and operating margin at 23.2%.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 101.3x leaves little room for execution misses.

Bear Case : XRN

The primary concerns for XRN are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

WELL profiles as a growth stock while XRN is a value play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.13 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

XRN scores higher overall (58/100 vs 57/100), backed by strong 37.8% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?